Physician profile
Stuart H Chen
NPI 1629211875
$9,485.08
in general payments reported to CMS, 2019-2025
18 companies · $3,757 in 2025
The $3,757 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,162 · 2020: $289 · 2021: $106 · 2022: $323 · 2023: $758 · 2024: $2,089 · 2025: $3,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,447 · Travel and Lodging: $3,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,447.48 |
| Travel and Lodging | $3,157.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,342.37 | 2023-2025 | Triclip, Mitraclip |
| Medtronic Vascular, INC. | $2,221.43 | 2019-2020 | |
| Edwards Lifesciences Corporation | $2,094.80 | 2023-2025 | Evoque, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $562.50 | 2022-2025 | Cobalt Dr Mri Surescan, Cg Future, Apollotm |
| Heartflow, INC. | $231.71 | 2024 | |
| Bracco Diagnostics INC. | $221.56 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.17 | 2019-2021 | |
| Cardiac Dimensions, INC. | $130.26 | 2023 | |
| Novo Nordisk INC | $125.00 | 2024 | |
| Stryker Corporation | $123.15 | 2021-2024 | Trevo, Transform |
| Merck Sharp & Dohme LLC | $54.61 | 2022 | |
| Novartis Pharmaceuticals Corporation | $48.91 | 2019-2022 | |
| Ge Healthcare | $39.88 | 2022-2025 | |
| Philips North America LLC | $34.19 | 2024 | (Ao0) Igt Devices Intracardiac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.28 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.11 | 2019 | |
| Ekos Corporation | $19.93 | 2019 | |
| Seqirus USA INC | $19.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.